Stay updated on Imvotamab in Non-Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site revision shown in the footer changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T03:25:48.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH website updates and says the agency is transitioning to use “Super Intelligence” instead of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-27T06:34:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision in the footer changed from v3.7.1 to v3.7.2; the page still shows a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-20T06:24:12.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T08:12:56.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the previous content and making the trial details temporarily inaccessible.
    Difference
    18%
    Check dated 2026-09-22T06:28:09.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a small update to the page's documentation/versioning rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-08-31T23:48:29.000Z thumbnail image

Stay in the know with updates to Imvotamab in Non-Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.